Drug Interaction Report

Dronedarone and Trospium / Xanomeline: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Dronedarone

Multaq
+

Trospium / Xanomeline

Cobenfy
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 146 documented Dronedarone interactions, 7 are rated moderate — including this one.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Cobenfy's xanomeline can briefly slow gut breakdown of dronedarone, possibly raising dronedarone levels and side effects; this is a theoretical concern your care team can manage by monitoring you. Report any new heart or stomach symptoms to your pharmacist or doctor.

Here's what's going on. Your heart-rhythm medicine, dronedarone (Multaq), is broken down in your body by an enzyme called CYP3A4. The xanomeline part of Cobenfy can briefly slow that same enzyme down in your gut. When that happens, a bit more dronedarone may get into your system than usual.

In plain terms, that could mean a little more of dronedarone's effect and a slightly higher chance of side effects, like nausea, tiredness, or heart-rhythm changes. This is a theoretical concern, not something proven to cause big problems. The good news is your care team can manage it easily by keeping an eye on how you feel. Let them know about any new symptoms.

Mechanism: Xanomeline (in Cobenfy) transiently inhibits intestinal CYP3A4. Dronedarone is a sensitive oral CYP3A4 substrate, so co-administration may increase dronedarone exposure (AUC/Cmax) via reduced first-pass gut metabolism. Neither agent's active form depends on CYP3A4 activation, so the effect is increased dronedarone exposure, not reduced efficacy.

  • Direction: increased dronedarone exposure and dose-related adverse effects (GI, QT prolongation, bradycardia).
  • Evidence: theoretical; magnitude not quantified.
  • Onset: unspecified.
  • Management: monitor for increased frequency/severity of dronedarone adverse reactions; consider ECG and symptom review. Dose may be individualized by the care team.
Onset
unspecified
Evidence
theoretical
Severity
Moderate

What happens

Increased oral sensitive CYP3A4 substrate exposure and an increased risk on severity and frequency of sensitive CYP3A4 substrate-related adverse reactions

Interaction Deep Dive

Within the gut, xanomeline produces a temporary, localized inhibition of CYP3A4, though it does not affect this enzyme systemically. When taken together with oral medications that are sensitive substrates of CYP3A4, xanomeline may raise the exposure of those oral sensitive CYP3A4 substrates. Such elevated exposure can lead to a greater frequency and/or severity of adverse reactions associated with these substrates. In cases of concurrent administration, patients should be watched for any rise in the frequency and/or severity of adverse reactions tied to oral drugs that are sensitive substrates of CYP3A41.

Why it happens (mechanism)

Inhibition of CYP3A4-substrate metabolism by xanomeline

How to manage this interaction

Keep taking both medicines as prescribed unless your prescriber tells you otherwise. This interaction is theoretical, and your care team can manage it by watching how you respond.

  • Watch for new or worsening dronedarone side effects, such as nausea, unusual tiredness, dizziness, a slow or irregular heartbeat, or fainting.
  • Your team may monitor you more closely (for example, checking your heart rhythm and how you feel), and your dose may be adjusted and individualized if needed.
  • Report any new symptoms to your pharmacist or prescriber, and don't start or stop either drug on your own.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Dronedarone and Trospium / Xanomeline together?

Cobenfy's xanomeline can briefly slow gut breakdown of dronedarone, possibly raising dronedarone levels and side effects; this is a theoretical concern your care team can manage by monitoring you. Report any new heart or stomach symptoms to your pharmacist or doctor. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Dronedarone and Trospium / Xanomeline interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Dronedarone and Trospium / Xanomeline interaction managed?

Keep taking both medicines as prescribed unless your prescriber tells you otherwise. This interaction is theoretical, and your care team can manage it by watching how you respond. Watch for new or worsening dronedarone side effects, such as nausea, unusual tiredness, dizziness, a slow or irregular heartbeat, or fainting. Your team may monitor you more closely (for example, checking your heart rhyt… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Dronedarone or Trospium / Xanomeline need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (1)

  1. Citation #1
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.